UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Self-reported symptom burden among patients receiving bevacizumab versus cetuximab containing regimens as second-line treatment of metastatic colorectal cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16598-e16598

2011

Volltextzugriff (PDF)

Willingness to pay to prevent chemotherapy-induced nausea and vomiting

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6068-6068

2011

Volltextzugriff (PDF)

Effect of induced transient arousal on obstructive apnea duration

Journal of applied physiology (1985), 1995-04, Vol.78 (4), p.1469-1476

1995

Volltextzugriff (PDF)

Abstract B77: Asian-American response to pemetrexed: Results from an observational study of second-line treatment of non-small cell lung cancer

Cancer epidemiology, biomarkers & prevention, 2012-10, Vol.21 (10_Supplement), p.B77-B77

2012

Volltextzugriff (PDF)

Sleep fragmentation and daytime sleepiness

Sleep (New York, N.Y.), 1984-01, Vol.7 (1), p.18-26

1984

Volltextzugriff (PDF)

A phase II study of bevacizumab with nab-paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5009-5009

2010

Volltextzugriff (PDF)

The Effect of Disease Progression on Patient Reported Outcomes in HER-2 Negative Metastatic Breast Cancer Patients

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5050-5050

2009

Volltextzugriff (PDF)

Prospective observational comparison of outcomes in African American and Caucasian patients receiving second-line treatment with pemetrexed for advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18008-e18008

2011

Volltextzugriff (PDF)

Daytime sleepiness and alertness in patients with Parkinson disease

Sleep (New York, N.Y.), 2004-08, Vol.27 (5), p.967-972

2004

Volltextzugriff (PDF)

Phase II trial of combination therapy with metronomic capecitabine (C) and fulvestrant (F) in the treatment of hormone receptor-positive metastatic breast cancer (HR+ MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11087-e11087

2011

Volltextzugriff (PDF)

Association of skin rash severity and overall survival in patients receiving erlotinib for pancreatic cancer in the community setting

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14508-e14508

2011

Volltextzugriff (PDF)

A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18023-e18023

2010

Volltextzugriff (PDF)

Testing procedures and reasons why HER2-positive breast cancer patients did not receive trastuzumab in the adjuvant setting

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e11072-e11072

2010

Volltextzugriff (PDF)

Psychosocial impact of cancer-related symptoms among patients with lung cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.6621-6621

2009

Volltextzugriff (PDF)

MIDD 0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABA A receptors without causing systemic immune suppression

Basic & clinical pharmacology & toxicology, 2019-07, Vol.125 (1), p.75-84

2019

Volltextzugriff (PDF)

Fragmenting sleep diminishes its recuperative value

Sleep (New York, N.Y.), 1987-12, Vol.10 (6), p.590-599

1987

Volltextzugriff (PDF)

Interim results of an observational study evaluating the impact of ethnic origin on the effect of second-line treatment with pemetrexed (P) for advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18055-e18055

2010

Volltextzugriff (PDF)

Effects of sleep deprivation on daytime sleepiness in primary insomnia

Sleep (New York, N.Y.), 2000-03, Vol.23 (2), p.215-219

2000

Volltextzugriff (PDF)

Sleep disorders in patients on continuous ambulatory peritoneal dialysis

Journal of the American Society of Nephrology, 1995-08, Vol.6 (2), p.192

1995

Volltextzugriff (PDF)

An observational study of the impact of ethnicity on patients treated for non-small cell lung cancer (NSCLC) in the second-line setting with pemetrexed: Preliminary results in African Americans

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20624-e20624

2009

Volltextzugriff (PDF)

Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1009-1009

2011

Volltextzugriff (PDF)

Evidence-based treatment protocol (ETP) usage in community oncology clinics

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6621-6621

2008

Volltextzugriff (PDF)

Daily oral topotecan: Utilization of a metronomic dosing schedule to treat recurrent or persistent solid tumors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2571-2571

2008

Volltextzugriff (PDF)

Prevalence of insomnia and associated symptoms in patients with cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.9098-9098

2007

Volltextzugriff (PDF)

Practice pattern for patients receiving secondline treatment for non-small cell lung cancer (NSCLC) with erlotinib in the community setting

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19102-19102

2008

Volltextzugriff (PDF)

26 – 50 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(84)
Tagungsberichte
(1)

Sprache

Englisch
(84)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(50)
Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Male
(33)
Female
(31)
Adult
(29)
Biological And Medical Sciences
(25)
Middle Aged
(25)
Neurosciences & Neurology
(20)
Clinical Neurology
(19)
Medical Sciences
(19)
Neurosciences
(17)
Insomnia
(13)
Psychology. Psychoanalysis. Psychiatry
(13)
Aged
(12)
Neurology
(10)
Sleep Initiation And Maintenance Disorders - Diagnosis
(10)
Psychiatry
(9)
Psychology
(9)
Psychopathology. Psychiatry
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Self-reported symptom burden among patients receiving bevacizumab versus cetuximab containing regimens as second-line treatment of metastatic colorectal cancer

Willingness to pay to prevent chemotherapy-induced nausea and vomiting

Effect of induced transient arousal on obstructive apnea duration

Abstract B77: Asian-American response to pemetrexed: Results from an observational study of second-line treatment of non-small cell lung cancer

Sleep fragmentation and daytime sleepiness

A phase II study of bevacizumab with nab-paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

The Effect of Disease Progression on Patient Reported Outcomes in HER-2 Negative Metastatic Breast Cancer Patients

Prospective observational comparison of outcomes in African American and Caucasian patients receiving second-line treatment with pemetrexed for advanced non-small cell lung cancer (NSCLC)

Daytime sleepiness and alertness in patients with Parkinson disease

Phase II trial of combination therapy with metronomic capecitabine (C) and fulvestrant (F) in the treatment of hormone receptor-positive metastatic breast cancer (HR+ MBC)

Association of skin rash severity and overall survival in patients receiving erlotinib for pancreatic cancer in the community setting

A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer

Testing procedures and reasons why HER2-positive breast cancer patients did not receive trastuzumab in the adjuvant setting

Psychosocial impact of cancer-related symptoms among patients with lung cancer

MIDD 0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABA A receptors without causing systemic immune suppression

Fragmenting sleep diminishes its recuperative value

Interim results of an observational study evaluating the impact of ethnic origin on the effect of second-line treatment with pemetrexed (P) for advanced non-small cell lung cancer (NSCLC)

Effects of sleep deprivation on daytime sleepiness in primary insomnia

Sleep disorders in patients on continuous ambulatory peritoneal dialysis

An observational study of the impact of ethnicity on patients treated for non-small cell lung cancer (NSCLC) in the second-line setting with pemetrexed: Preliminary results in African Americans

Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV)

Evidence-based treatment protocol (ETP) usage in community oncology clinics

Daily oral topotecan: Utilization of a metronomic dosing schedule to treat recurrent or persistent solid tumors

Prevalence of insomnia and associated symptoms in patients with cancer

Practice pattern for patients receiving secondline treatment for non-small cell lung cancer (NSCLC) with erlotinib in the community setting

Suchergebnisse filtern